Related Experiment Video

Updated: May 16, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Utilizing the folate receptor for active targeting of cancer nanotherapeutics

Grant L Zwicke1, G Ali Mansoori, Constance J Jeffery

  • 1Department of Biological Sciences, University of Illinois at Chicago, Chicago, IL, USA.

Nano Reviews
|December 15, 2012
PubMed

Insights

Specialized nanoparticles are being developed for cancer detection and treatment. Folate nanoconjugates target folate receptors, which are overexpressed in tumors, for more effective and less toxic therapies.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Nanoparticle development for cancer detection and treatment is rapidly advancing.
  • Targeted therapies aim to increase efficacy and reduce toxicity by concentrating treatments on cancer cells.
  • Folate receptors are significantly overexpressed on many cancer cell surfaces, presenting a promising target.

Purpose of the Study:

  • To review recent studies utilizing folate nanoconjugates for cancer targeting.
  • To explore the potential of targeting folate receptors for improved cancer imaging and therapy.

Main Methods:

  • Focus on recent research involving folate nanoconjugates.
  • Analysis of studies employing folate receptor-targeted strategies.
  • Review of nanoparticle-based approaches for cancer treatment and detection.

Main Results:

  • Folate nanoconjugates show promise in targeting cancer cells via folate receptors.
  • Targeted delivery can potentially enhance therapeutic efficacy.
  • Reduced systemic toxicity is a key potential benefit of this approach.

Conclusions:

  • Folate receptor-targeted nanoconjugates represent a viable strategy for enhancing cancer detection and treatment.
  • Exploiting folate receptor overexpression offers a pathway to more precise and less harmful cancer therapies.
  • Further research in this area could lead to significant clinical advancements.
Keywords:
99mTc-EC20cancerconjugatesdoxorubicinfolatefolate receptorfolic acidgoldnanoaggregatesnanotechnology

More Related Videos

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles08:02

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...